相关实验视频

Updated: Jan 10, 2026

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

脂质纳米颗粒的内体体逃逸:对文献数据的视角

¹Department of Chemistry and Biochemistry, The Ohio State University, 484 West 12th Avenue, Columbus, Ohio 43210, United States.

|November 20, 2025

概括

脂质纳米颗粒 (LNPs) 通过通过囊泡芽和崩 (VBC) 机制通过逃离内体传递核酸. 这个过程形成了细胞质聚合物,为有效的基因疗法创造了一个新的瓶.

科学领域:

生物技术和纳米医学
药物输送系统药物输送系统
分子和细胞生物学分子和细胞生物学

背景情况:

通过脂质纳米颗粒 (LNP) 进行细胞内核酸的输送受到低效的内体细胞逃逸的阻碍.
目前存在的内体逃生模型缺乏全面的验证和足够的机制理解,以合理设计LNP.
控制LNP内体逃逸和随后的细胞内贩运的精确机制尚不清楚.

研究的目的:

重新评估现有数据,并提供强有力的证据证明LNP内体逃逸中的囊泡芽和崩 (VBC) 机制.
为了识别和描述核酸输送在内体逃逸后的潜在后续瓶.
为合理的LNP设计建立一个理论框架,以提高交付效率.

主要方法:

重新评估现有关于LNP介导核酸输送的实验数据.
对拟议的内体体逃生机制的分析,包括质子海绵效应和膜不稳定.
鉴定和表征LNP内体逃逸后的细胞内事件.

主要成果:

强有力的证据支持囊泡芽和崩 (VBC) 机制作为LNP内体逃生的主要途径.
内体逃生触发了细胞质内不溶性脂质/核酸聚合物的形成.
这些细胞质聚合物的溶解速度代表了功能交付的额外,潜在的速度限制,瓶.

结论:

这种VBC机制使以前关于LNP内体逃逸的令人费解的实验观测得以协调.
细胞质聚合物的形成和溶解为核酸输送提供了一个新的,关键的瓶.
了解VBC机制和聚合物形成为合理的LNP设计提供了一条途径,以提高基因疗法的疗效.

关键词:

药物输送是药物输送的过程.细胞内体逃脱的方法脂质纳米颗粒是一种纳米粒子.膜运输是一种膜运输.囊泡的芽和崩发生.

更多相关视频

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Intralumenal Vesicles and Multivesicular Bodies

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...